Literature DB >> 12911311

Rho-specific Bacillus cereus ADP-ribosyltransferase C3cer cloning and characterization.

Christian Wilde1, Martin Vogelsgesang, Klaus Aktories.   

Abstract

C3-like ADP-ribosyltransferases represent an expanding family of related exoenzymes, which are produced by Clostridia and various Staphylococcus aureus strains. Here we report on the cloning and biochemical characterization of an ADP-ribosyltransferase from Bacillus cereus strain 2339. The transferase encompasses 219 amino acids; it has a predicted mass of 25.2 kDa and a theoretical isoelectric point of 9.3. To indicate the relationship to the family of C3-like ADP-ribosyltransferases, we termed the enzyme C3cer. The amino acid sequence of C3cer is 30 to 40% identical to other C3-like exoenzymes. By site-directed mutagenesis, Arg(59), Arg(97), Tyr(151), Arg(155), Thr(178), Tyr(180), Gln(183), and Glu(185) of recombinant C3cer were identified as pivotal residues of enzyme activity and/or protein substrate recognition. Precipitation experiments with immobilized RhoA revealed that C3cerTyr(180), which is located in the so-called "ADP-ribosylating toxin turn-turn" (ARTT) motif, plays a major role in the recognition of RhoA. Like other C3-like exoenzymes, C3cer ADP-ribosylates preferentially RhoA and RhoB and to a much lesser extent RhoC. Because the cellular accessibility of recombinant C3cer is low, a fusion toxin (C2IN-C3cer), consisting of the N-terminal 225 amino acid residues of the enzyme component of C2 toxin from Clostridium botulinum and C3cer was used to study the cytotoxic effects of the transferase. This fusion toxin caused rounding up of Vero cells comparable to the effects of Rho-inactivating toxins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12911311     DOI: 10.1021/bi034583b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

Review 1.  C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins.

Authors:  Martin Vogelsgesang; Alexander Pautsch; Klaus Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-12-05       Impact factor: 3.000

2.  The Staphylococcus aureus epidermal cell differentiation inhibitor toxin promotes formation of infection foci in a mouse model of bacteremia.

Authors:  Patrick Munro; Maxime Benchetrit; Marie-Anne Nahori; Caroline Stefani; René Clément; Jean-François Michiels; Luce Landraud; Olivier Dussurget; Emmanuel Lemichez
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

3.  Structural basis for the NAD-hydrolysis mechanism and the ARTT-loop plasticity of C3 exoenzymes.

Authors:  Julie Ménétrey; Gilles Flatau; Patrice Boquet; André Ménez; Enrico A Stura
Journal:  Protein Sci       Date:  2008-03-27       Impact factor: 6.725

Review 4.  Novel bacterial ADP-ribosylating toxins: structure and function.

Authors:  Nathan C Simon; Klaus Aktories; Joseph T Barbieri
Journal:  Nat Rev Microbiol       Date:  2014-07-14       Impact factor: 60.633

5.  C3larvin toxin, an ADP-ribosyltransferase from Paenibacillus larvae.

Authors:  Daniel Krska; Ravikiran Ravulapalli; Robert J Fieldhouse; Miguel R Lugo; A Rod Merrill
Journal:  J Biol Chem       Date:  2014-12-04       Impact factor: 5.157

6.  Rho GTPase Recognition by C3 Exoenzyme Based on C3-RhoA Complex Structure.

Authors:  Akiyuki Toda; Toshiharu Tsurumura; Toru Yoshida; Yayoi Tsumori; Hideaki Tsuge
Journal:  J Biol Chem       Date:  2015-06-11       Impact factor: 5.157

Review 7.  Therapeutic effects of Clostridium botulinum C3 exoenzyme.

Authors:  Ingo Just; Astrid Rohrbeck; Stefanie C Huelsenbeck; Markus Hoeltje
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-31       Impact factor: 3.000

8.  High prevalence of edin-C encoding RhoA-targeting toxin in clinical isolates of Staphylococcus aureus.

Authors:  P Munro; R Clément; J-P Lavigne; C Pulcini; E Lemichez; L Landraud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-11       Impact factor: 3.267

9.  Difference in the biological effects of Clostridium difficile toxin B in proliferating and non-proliferating cells.

Authors:  Marta Lica; Florian Schulz; Ilona Schelle; Martin May; Ingo Just; Harald Genth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01-07       Impact factor: 3.000

10.  Axonal Development: RhoA Restrains but Does Not Specify.

Authors:  Anton Omelchenko; Bonnie L Firestein
Journal:  Curr Biol       Date:  2019-11-18       Impact factor: 10.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.